ACTG Announces Launch of Clinical Trial Evaluating Combination of Three Novel Immune-based Therapies for HIV Cure
April 19, 2024 09:00 ET
|
ACTG
ACTG Announces Launch of Clinical Trial Evaluating Combination of Three Novel Immune-based Therapies for HIV Cure
ACTG CROI Presentation Demonstrates Superiority of HepB-CpG Vaccine Over Conventional Hepatitis B Vaccine Among People Living With HIV Who Have Not Previously Responded to Vaccination
March 06, 2024 15:30 ET
|
ACTG
ACTG at CROI: HepB-CPG Vaccine Outperforms Standard Hepatitis B Vaccine for HIV Patients with Previous Vaccination Failures
ACTG Presents Study at CROI Demonstrating Efficacy of Long-Acting Injectable Treatment Among People Who Had Previously Been Unable to Maintain Viral Suppression on Daily Oral Medication
March 06, 2024 10:45 ET
|
ACTG
ACTG Study Shows Long-Acting Injectable Treatment Effective for Those Struggling with Viral Suppression on Daily Oral Medication
ACTG CROI Presentations Show That Semaglutide Improves Metabolic-Associated Steatotic Liver Disease Among People Living With HIV
March 05, 2024 13:15 ET
|
ACTG
ACTG CROI PRESENTATIONS SHOW THAT SEMAGLUTIDE IMPROVES METABOLIC-ASSOCIATED STEATOTIC LIVER DISEASE AMONG PEOPLE LIVING WITH HIV
ACTG Presents Study at CROI Elucidating Mechanism of CMV on Aging-Related Pathways in HIV
March 04, 2024 10:00 ET
|
ACTG
ACTG PRESENTS STUDY AT CROI ELUCIDATING MECHANISM OF CMV ON AGING-RELATED PATHWAYS IN HIV
ACTG Announces Launch of Clinical Trial Evaluating Drug-Drug Interaction in Shortened Tuberculosis Regimen Among People Living with HIV
February 14, 2024 11:48 ET
|
ACTG
ACTG Announces Launch of Clinical Trial Evaluating Drug-Drug Interaction in Shortened Tuberculosis Regimen Among People Living with HIV
ACTG Announces Launch of Clinical Trial Evaluating Novel Treatment for Tuberculous Meningitis
December 07, 2023 15:10 ET
|
ACTG
Regimen Would Decrease Duration of Treatment from Nine to Six Months LOS ANGELES, Dec. 07, 2023 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious...
ACTG Announces Publication of REPRIEVE Trial in New England Journal of Medicine and Presentation at IAS 2023
July 23, 2023 19:45 ET
|
AIDS Clinical Trials Group Network
LOS ANGELES, July 23, 2023 (GLOBE NEWSWIRE) -- The AIDS Clinical Trials Group (ACTG), a global clinical trials network focused on HIV, tuberculosis, hepatitis B and emerging infectious diseases,...
ACTG Announces Publication of New Insights Into HIV Reservoirs and Prospects for Remission in the Journal of Infectious Diseases
March 27, 2023 16:19 ET
|
AIDS Clinical Trials Group Network
LOS ANGELES, March 27, 2023 (GLOBE NEWSWIRE) -- The AIDS Clinical Trials Group (ACTG), the world’s largest HIV research network, today announced the publication of “Varied Patterns of Decay of...
ACTG Announces Publication of Pivotal Hepatitis C Study in Clinical Infectious Diseases
March 27, 2023 09:42 ET
|
AIDS Clinical Trials Group Network
LOS ANGELES, March 27, 2023 (GLOBE NEWSWIRE) -- The AIDS Clinical Trials Group (ACTG), the world’s largest HIV research network, is announcing the publication of “Perspectives on Adherence from the...